Oliver Maddocks, Co-Founder & CSO of Faeth Therapeutics
Professional Overview
Oliver Maddocks is the Co-Founder and Chief Scientific Officer (CSO) of Faeth Therapeutics, a Glasgow-based biotechnology company pioneering innovative cancer therapies. With extensive expertise in cancer research and drug development, Maddocks oversees the company's scientific strategy and leads its team of world-class researchers in advancing cutting-edge cancer treatments.
Experience Summary
Current Role
As the Co-Founder and CSO of Faeth Therapeutics, Maddocks is responsible for driving the company's scientific vision and ensuring the successful translation of its groundbreaking research into viable clinical solutions. He leads a team of talented scientists and researchers, collaborating closely with them to develop novel therapeutic approaches that have the potential to transform the cancer treatment landscape.
Under Maddocks' leadership, Faeth Therapeutics has secured significant funding and established strategic partnerships with leading institutions, positioning the company as a key player in the field of oncology.
Career Progression
Maddocks has built an impressive career in the field of cancer research, with a diverse background spanning academic and industry settings. Prior to co-founding Faeth Therapeutics, he held the role of Professor and Group Leader at the University of Glasgow, where he conducted pioneering research on cancer metabolism and its implications for targeted therapies.
Maddocks has also held postdoctoral positions at the Cancer Research UK Beatson Institute and the University of Maryland School of Medicine, where he honed his expertise in cancer biology and drug discovery. His early career experience includes roles as a scientist at the MRC Human Genetics Unit and a pharmacist at the NHS.
Academic Background
Maddocks holds a PhD in Cancer Biology from the University of Edinburgh, where he specialized in understanding the metabolic adaptations of cancer cells and their implications for therapeutic development. He has been recognized for his academic achievements, including being appointed as an Honorary Professor at the University of Glasgow.
Areas of Expertise
- Cancer biology and metabolism
- Oncology drug discovery and development
- Translational research and clinical trial design
- Scientific leadership and team management
- Collaboration and partnership building
Professional Impact
Maddocks has made significant contributions to the field of cancer research, with his work leading to the development of several promising therapeutic candidates. He has authored numerous peer-reviewed publications in high-impact journals and has been invited to present his research at prestigious international conferences.
As the Co-Founder and CSO of Faeth Therapeutics, Maddocks is driving the company's mission to bring innovative cancer treatments to patients in need. Under his leadership, the company has established valuable partnerships and secured funding to accelerate the translation of its research into clinical applications.
Conclusion
With his extensive expertise in cancer biology, drug development, and scientific leadership, Oliver Maddocks is positioned to make a substantial impact on the future of cancer treatment. As the Co-Founder and CSO of Faeth Therapeutics, he is dedicated to advancing the company's groundbreaking research and delivering transformative cancer therapies to patients worldwide.
